Melanotan II has been thoroughly analyzed via clinical trials, and they showed that Melanotan II was safely able to promote melanogenesis (the process of melanocytes in your body producing more melanin)
Perform a comprehensive assessment of the patients risk factors, including obesity/overweight, hypertension, dyslipidemia, smoking history, family history of premature coronary disease, chronic kidney disease (CKD), and presence of albuminuria
Nevertheless, for this reason alone, current evidence is not confirmatory
The goal of any medical weight loss program should be safe, effective results aligned with your individual health profile and the plan you build with your physician
They contain the same active ingredient (semaglutide) but are not the same product